. . . . . . . "[Since even the most sensitive AQP4 antibody tests fail to mark about 20-30% of the NMO cases, while 20-30% of positive patients have 'atypical' or MS-like variants, it remains to be clarified if NMO, as a clinical entity, can still be considered a disease rather than a syndrome, with more possible pathogenetic mechanisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:10:41+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .